NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

 

NetScientific is a holding company of its various technology businesses. It is not an AIM Investing Company

Board and Management

Sector-specialist senior management team with extensive commercial experience.

  • John Clarkson

    John Clarkson, Non-Executive Chairman of the Group, is an experienced business professional and qualified accountant, who had a successful early career working in various …

    Non-Executive Chairman
  • Dr Ilian Iliev

    Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital, a London-based investor in B2B companies in the industrial high-tech, energy, circular …

    Chief Executive Officer
  • Professor Stephen Smith

    Professor Stephen Smith, Non-Executive Director, joined the NetScientific Board in 2016. Stephen has held senior leadership roles in the NHS and academia. He has …

    Non-Executive Director
  • Stephen Crowe

    Stephen Crowe, CFO, A commercial, growth-focused and highly experienced Finance Leader with over 20+ years of experience in a wide range of financial institutions …

    CFO

News

NetScientific plc (“NetScientific” or the “Company”) ProAxsis Limited appoints DiaPharma as distributor to key North America region London, UK – 19 November 2020 – NetScientific plc (AIM: NSCI), the …

NetScientific plc (“NetScientific” or the “Company”) PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine PDS0203 prioritized for clinical development by PDS Biotech and Farmacore …

NetScientific plc (“NetScientific” or the “Company”)   PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck VERSATILE-002 …

NetScientific healthcare technology group